// App-Quantinova.ai

: Computational pathology–based HER2 quantification to identify novel biomarkers in gastric cancer (GC).

Researchers

Presenter

  • Ansh Kapil

Principal Investigators

  • Henrik Failmezger

  • Andreas Spitzmüller

  • Jessica Chan

  • Susanne Haneder

  • Anatoliy Shumilov

  • Alice Barkell

  • Toshihiro Oguma

  • Koichiro Inaki

  • Fumitaka Suto

  • John Allard

  • Jeeyun Lee

  • J Carl Barrett

  • Günter Schmidt

  • Hadassah Sade

  • Danielle Carroll

  • Fabiola Cecchi

Medical Centers

  • AstraZeneca, Waltham, MA

  • AstraZeneca Computational Pathology GmbH, Early Oncology Translational Medicine, Munich, Germany

  • Daiichi-Sankyo, Tokyo, Japan.

  • AstraZeneca Translational Medicine, Early Oncology, Gaithersburg, MD

  • Daiichi Sankyo, Basking Ridge, NJ

  • Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

  • AstraZeneca Translational Medicine, Early Oncology, Cambridge, United Kingdom

Locations

  • United Kingdom

  • Republic of South Korea

  • United States

  • Germany

  • Japan

Companies

  • Daiichi Sankyo Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • NCT03329690

  • NCT04014075

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved